The efficacy of amine fluoride/stannous fluoride in the suppression of morning breath odour
- PMID: 12445227
- DOI: 10.1034/j.1600-051x.2002.291010.x
The efficacy of amine fluoride/stannous fluoride in the suppression of morning breath odour
Abstract
Background: Breath odour is a complaint encountered worldwide, often linked to microbial overload in the oral cavity. This double blind, crossover, randomised study assessed the efficacy of several antiseptic mouthrinses or slurry vs. a control solution in the prevention of morning bad breath during an experimental period of 7 days without mechanical plaque control.
Methods: Sixteen dental students with a healthy periodontium abolished, after a thorough professional cleaning, all means of mechanical plaque control during five experimental periods of 7 days, interleaved by washout periods of at least 3 weeks. During each experimental period, as the only oral hygiene measure, the students rinsed twice a day with one of the following formulations (in a randomised order): a 0.2% chlorhexidine-alcohol mouthrinse (CHX-Alc), a 0.05% CHX + 0.05% cetylpyridinium chloride + 0.14% zinc lactate mouthrinse (CHX-CPC-Zn), an amine fluoride/stannous fluoride (125 ppm F-/125 ppm F-) containing mouthrinse (AmF/SnF2Mr), a slurry of a tooth paste (AmF/SnF2Sl) containing amine fluoride (350 ppm F-) and stannous fluoride (1050 ppm F-) and a placebo solution (placebo). At days 0, 3 and 7, morning breath was scored via VSC level measurements of the mouth air, and organoleptic ratings of the mouth air and tongue coating. At the same visits both the degree of gingival inflammation and the de novo plaque formation were rated. At the end of each period a questionnaire for subjective ratings was completed and microbiological samples were taken from the tongue dorsum, the saliva and the supragingival plaque for anaerobic and aerobic culturing.
Results: Although oral hygiene during the experimental periods was limited to rinsing, bad breath parameters systematically improved (P < 0.001) with the three mouthrinses (CHX-Alc, CHX-CPC-Zn, AmF/SnF2Mr), with a superiority of the CHX-CPC-Zn solution when only VSC values were considered (P < 0.003). The AmF/SnF2 slurry and the placebo solution showed only minor changes with time. The three mouthrinses reduced significantly (P < 0.001) the bacterial load (aerobic & anaerobic) in the saliva (>or= 0.5 log reduction with a superiority (P < 0.005) for the CHX-Alc when compared to the two others). Changes in the bacterial load on the tongue dorsum could only be detected for the CHX-Alc solution (0.5 log). The antibacterial effect of the placebo solution and the slurry were negligible. The composition of microflora on the other hand did not reveal significant changes. The de novo supragingival plaque formation was significantly (P < 0.05) inhibited by the three mouthrinses with a slight superiority for the CHX-Alc solution. The degree of gingival inflammation at day 7 remained low (< 0.16) for all products. The CHX-Alc solution scored significantly worse for the subjective evaluation (questionnaires) concerning taste and sensitivity of tongue).
Conclusions: The results of this study demonstrate that morning breath odour can be successfully reduced by the sole twice daily use of CHX-Alc, CHX-CPC-Zn or AmF/SnF2Mr mouthrinses, which all significantly reduced the bacterial load in the saliva and retarded the de novo plaque formation.
Similar articles
-
Effect of different mouthrinses on morning breath.J Periodontol. 2001 Sep;72(9):1183-91. doi: 10.1902/jop.2000.72.9.1183. J Periodontol. 2001. PMID: 11577950 Clinical Trial.
-
Effect of different chlorhexidine formulations in mouthrinses on de novo plaque formation.J Clin Periodontol. 2001 Dec;28(12):1127-36. doi: 10.1034/j.1600-051x.2001.281207.x. J Clin Periodontol. 2001. PMID: 11737510 Clinical Trial.
-
The impact of periodontal therapy and the adjunctive effect of antiseptics on breath odor-related outcome variables: a double-blind randomized study.J Periodontol. 2005 May;76(5):705-12. doi: 10.1902/jop.2005.76.5.705. J Periodontol. 2005. PMID: 15898930 Clinical Trial.
-
Experiences with amine fluoride containing products in the management of dental hard tissue lesions focusing on Hungarian studies: a review.Acta Med Acad. 2013 Nov;42(2):189-97. doi: 10.5644/ama2006-124.86. Acta Med Acad. 2013. PMID: 24308398 Review.
-
Review of the treatment strategies for oral malodour.Clin Oral Investig. 2002 Mar;6(1):1-10. doi: 10.1007/s00784-002-0152-9. Clin Oral Investig. 2002. PMID: 11996157 Review.
Cited by
-
Halitosis: could it be more than mere bad breath?Intern Emerg Med. 2011 Aug;6(4):315-9. doi: 10.1007/s11739-010-0492-4. Epub 2010 Dec 8. Intern Emerg Med. 2011. PMID: 21140240 Review.
-
Halitosis, oral health and quality of life during treatment with Invisalign(®) and the effect of a low-dose chlorhexidine solution.J Orofac Orthop. 2010 Nov;71(6):430-41. doi: 10.1007/s00056-010-1040-6. Epub 2010 Nov 17. J Orofac Orthop. 2010. PMID: 21082306 English, German.
-
Comparison of the Effect of Er,Cr:YSGG Laser and Halita Mouthwash on Oral Malodor in Patients With Chronic Periodontitis: A Randomized Clinical Trial.J Lasers Med Sci. 2021 Jun 20;12:e26. doi: 10.34172/jlms.2021.26. eCollection 2021. J Lasers Med Sci. 2021. PMID: 34733749 Free PMC article.
-
Efficacy of antioxidant mouthwash in the reduction of halitosis: A randomized, double blind, controlled crossover clinical trial.J Dent Sci. 2021 Mar;16(2):621-627. doi: 10.1016/j.jds.2020.10.005. Epub 2020 Oct 23. J Dent Sci. 2021. PMID: 33854711 Free PMC article.
-
Prevalence of oral malodour and its relationship with oral parameters in Indian children aged 7-15 years.Eur Arch Paediatr Dent. 2014 Aug;15(4):251-8. doi: 10.1007/s40368-014-0109-0. Epub 2014 Feb 26. Eur Arch Paediatr Dent. 2014. PMID: 24569936
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials